Biapical Emphysema: Causes, Symptoms & Management

Biapical emphysema refers to predominant upper‑lobe (apical) alveolar destruction — a pattern classically associated with smoking but also seen in other conditions.

Etiology

• Smoking: >90% of cases; smoke particles deposit apically due to ventilation/perfusion gradients.
• Alpha‑1 antitrypsin deficiency (A1AD): Panacinar, basilar predominance — but can be apical in smokers with A1AD.
• Occupational: Silica, coal, cadmium, welding fumes.
• HIV‑associated: Apical cystic changes.
• Genetic: SERPINA1 (A1AT), MMP12, GST variants.

Symptoms

• Dyspnea on exertion (progressive).
• Chronic cough ± scant sputum.
• Wheezing (airway collapse).
• Weight loss, muscle wasting (cachexia in advanced).
• Cyanosis (late).

Diagnosis

• Spirometry: FEV₁/FVC <0.70 (post‑bronchodilator); FEV₁ % predicted stages severity.
• CT: Upper‑lobe bullae, vascular pruning, absent centrilobular vessels.
• A1AT level + phenotype if <45 yrs or family history.

Management

• Smoking cessation — single most effective intervention (slows FEV₁ decline).
• Bronchodilators: LAMA (tiotropium) ± LABA (formoterol, salmeterol, indacaterol).
• ICS only if eosinophilic inflammation or asthma overlap (blood eosinophils ≥300).
• Pulmonary rehabilitation — improves exercise capacity, QoL.
• Oxygen if resting SpO₂ ≤88% or PaO₂ ≤55 mmHg.
• Lung volume reduction surgery (LVRS) / endobronchial valves — select upper‑lobe predominant, low exercise capacity.
• Transplant evaluation for end‑stage.